MCP-1 is also known to possess anti-tumor attributes and can compromise the BBB to translocate from the brain into the peripheral system to cause recruitment of immune cells such as M1-like macrophages and activated NK cells [31, 45, 64, 65]. The gene discussed is CCL2; the disease is neoplasm.